Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
0.637
-0.093 (-12.75%)
At close: Apr 28, 2026, 4:00 PM EDT
0.678
+0.041 (6.48%)
After-hours: Apr 28, 2026, 4:23 PM EDT
Silexion Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2013 | FY 2012 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
| Selling, General & Admin | 4.49 | 6.76 | 0.97 | 0.24 | 0.17 |
| Research & Development | 7.14 | 5.82 | 3.71 | 1.12 | 0.79 |
| Operating Expenses | 11.63 | 12.57 | 4.68 | 1.36 | 0.95 |
| Operating Income | -11.63 | -12.57 | -4.68 | -1.36 | -0.95 |
| Interest Expense | -0.01 | -0.03 | - | -0 | -0 |
| Interest & Investment Income | 0.16 | 0.03 | 0.15 | 0 | 0.01 |
| Currency Exchange Gain (Loss) | -0.13 | -0.25 | -0.45 | 0 | 0.01 |
| Other Non Operating Income (Expenses) | -0.29 | -3.69 | -0.1 | - | - |
| Pretax Income | -11.91 | -16.51 | -5.08 | -1.36 | -0.94 |
| Income Tax Expense | 0 | 0.01 | 0.03 | - | - |
| Earnings From Continuing Operations | -11.91 | -16.52 | -5.11 | -1.36 | -0.94 |
| Minority Interest in Earnings | - | 0.08 | 0.17 | - | - |
| Net Income | -11.91 | -16.44 | -4.94 | -1.36 | -0.94 |
| Net Income to Common | -11.91 | -16.44 | -4.94 | -1.36 | -0.94 |
| Shares Outstanding (Basic) | 1 | 0 | - | - | - |
| Shares Outstanding (Diluted) | 1 | 0 | - | - | - |
| Shares Change (YoY) | 3093.26% | - | - | - | - |
| EPS (Basic) | -8.96 | -394.93 | - | - | - |
| EPS (Diluted) | -8.96 | -394.93 | - | - | - |
| Free Cash Flow | -10.83 | -8.42 | -4.54 | -0.8 | -0.91 |
| Free Cash Flow Per Share | -8.14 | -202.19 | - | - | - |
| EBITDA | -11.62 | -12.55 | -4.64 | -1.36 | -0.95 |
| D&A For EBITDA | 0.01 | 0.03 | 0.05 | 0 | 0 |
| EBIT | -11.63 | -12.57 | -4.68 | -1.36 | -0.95 |
Source: S&P Capital IQ. Standard template.
Financial Sources.